July 19 - 22, 2019
Hyatt Regency San Francisco
San Francisco, California
Abstract submission deadline: Wednesday, May 1
Advance registration deadline: Friday, June 7
Conference CochairsCrystal L. Mackall, Stanford University School of Medicine, Stanford, CaliforniaPatrick Hwu, The University of Texas MD Anderson Cancer Center, Houston, Texas
This AACR Special Conference on Immune Cell Therapies for Cancer will focus on the successes and challenges of utilizing a patient’s immune cells to recognize and attack their own cancerous cells. The organizers have designed a meeting that will maximize collaboration between researchers, clinicians, and industry professionals. World-renowned scientists in the field will expand our understanding of targeting solid tumors with CAR T cells, NK and other immune cell therapies, optimization of target antigens for engineered T cells, genetic engineering to enhance immune cell function, and novel approaches for gene delivery. Internationally respected oncologists will provide clinical updates and introduce novel combination strategies. And top industry professionals will brainstorm how to drive down costs of adoptive cell therapies. Please join the conversation, which will run the spectrum from the basic science of engineered vectors to the latest results of clinical trials in patients.